Monitoring of treatment with bevacizumab in patients with metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2420410
下载链接
链接失效反馈官方服务：
资源简介：
Study hypothesis: Observational study, recording safety according to the National Cancer Institute Common Toxicity Criteria (NCI CTC), version 3.0 and evaluating efficacy in standard clinical practice.
Primary outcome(s): 1. Safety of treatment with bevacizumab
2. Response rate: Response Evaluation Criteria in Solid Tumors (RECIST)
3. Rate of radical surgical resection (R0 resection)
创建时间：
2007-12-15
